反応式
[Cl:1][C:2]1[NH:3][C:4]2[CH:10]=[CH:9][CH:8]=[CH:7][C:5]=2[N:6]=1.[C:11]1([CH:17]([C:21]2[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=2)[CH2:18][CH2:19][NH2:20])[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=1.Cl>C(Cl)Cl>[N:6]1[C:5]2[CH:7]=[CH:8][CH:9]=[CH:10][C:4]=2[NH:3][C:2]=1[NH:20][CH2:19][CH2:18][CH:17]([C:11]1[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=1)[C:21]1[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=1.[ClH:1]参加物
6
実験手順
The title compound was prepared from 2-chlorobenzimidazole and 3,3-diphenyl-propylamine by Procedure A. The reaction mixture was added dilute aqueous HCl and CH2Cl2. From the CH2Cl2 phase a precipitate was isolated by filtration yielding the title compound in pure form as its HCl salt (mp 136.5-137.5° C.). MS(ES+) m/z 328 ([M+1]+, 100). 1NMR (DMSO-d6) δ 2.43 (m, 2H), 3.28 (m, 2H), 4.15 (t, 1H), 7.15-7.35 (m, 14H), 9.00 (m, 1H), 12.7 (br s, 1H).
出典と根拠
- ORDレコード
- ord-00c567a1ba8b42f4a39ab2d6eb23c619
- 出典データセット
- uspto-grants-2010_06
- 特許番号
- US07737167B2
関連ノート
読み込み中…